Silexion Therapeutics SLXN
NASDAQ SLXN
$0.17 +0.01 (+8.82%)
As of: Oct 21, 2026 · 2:37 PM EDT

Silexion Therapeutics (SLXN) FCF Margin (2024 - 2025)

Updated

Analysis

Silexion Therapeutics (SLXN) FCF Margin (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn 28.82%
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn 18.33%
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn 26.96%
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 6.55%
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn 34.70%
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn 44.00%
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn 2.01%
10 Silexion Therapeutics 114,787.95 -19.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -27,322.22%
Dec 31, 2024 -12,191.67%
API Access

Silexion Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=SLXN&period=max&api_key=YOUR_API_KEY